You just read:

Vyxeos® Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia

News provided by

Jazz Pharmaceuticals plc

Aug 27, 2018, 02:00 ET